Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lyka Labs Ltd. Capital/Financing Update 2026

Apr 9, 2026

62602_rns_2026-04-09_9473cfc9-8b73-45cf-9a02-bd52cc59be35.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [452 x 44] intentionally omitted <==

9[th] April, 2026

BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] Floor, Dalal Street, Plot No. C/1, G. Block, Mumbai- 400 001. Bandra Kurla Complex, Bandra (East), Mumbai - 400 051.

Scrip Code: 500259 Scrip Code: LYKALABS

Subj.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Update on the Scheme of Amalgamation Dear Sir/Madam,

This is in continuation of our earlier communication(s) regarding the subject matter cited above, we wish to inform you that the Scheme of Amalgamation of Lyka Exports Limited (“Transferor Company”) with Lyka Labs Limited (“Transferee Company”) and their respective shareholders and creditors, has been sanctioned by the Hon’ble National Company Law Tribunal, Ahmedabad Bench (‘NCLT’) vide its Order dated 16th March, 2026. The certified true copy of the order was received on 24[th] March, 2026.

We wish to inform that, the certified copy of NCLT order has been filed with the Registrar of Companies, Ahmedabad by both the Transferor Company and the Transferee Company on 8[th] April, 2026 and accordingly, the Scheme has become effective from Wednesday, 8[th] April, 2026. The Appointed Date for the Scheme is 01st April, 2022.

We further wish to inform that in terms of the Scheme, the authorized share capital of the Company automatically stands increased to the extent of the aggregate authorized share capital of Transferor Company, upon effectiveness of the Scheme. Accordingly, Clause V of the Memorandum of Association of the Company pertaining to the authorized share capital, stands replaced/ substituted by the following Clause V:

"The Authorised Share Capital of the Company is Rs.59,00,00,000 (Rupees Fifty-Nine Crores Only) divided into 5,70,00,000 (Five Crores Seventy Lakhs Only) Equity shares of Rs.10 (Rupees Ten only) each and 2,00,000 (Two Lakhs) Redeemable Preference Shares of Rs. 100/(Rupees One Hundred Only).”

. Kindly take the above on record.

For Lyka Labs Limited

SHAILENDRA Digitally signed by SHAILENDRA KUMAR KUMAR AGRAWAL Date: 2026.04.09 AGRAWAL 16:20:52 +05'30' Shailendra Agrawal Company Secretary

==> picture [451 x 30] intentionally omitted <==